Innovation in Cancer, Infectious Disease Research

News   Jan 20, 2017 | Original story from UC Berkeley

 
Innovation in Cancer, Infectious Disease Research

Stephen Isaacs, CEO of Aduro Biotech, at the launch of the IVRI on March 23. (Peg Skorpinski photos)

 
 
 

RELATED ARTICLES

“Nanokicking” Technology Enables Breakthrough in the Culture of 3D Mineralised Bone Tissue

News

Researchers have grown 3D samples of mineralised bone from human mesenchymal stem cells for the first time without typical osteoinductive media.

READ MORE

Cancer Cells’ Energy Source Blocked by Natural Compound

News

Researchers have not only untangled an unusual wiring system that cancer cells use for carbohydrate metabolism, but also identified a natural compound that appears to selectively shut down this system in laboratory studies.

READ MORE

Gene Immunotherapy Approach Prevents and Reverses Symptoms of Multiple Sclerosis

News

Researchers used a viral vector to deliver a gene encoding a myelin sheath protein to the liver, thereby inducing robust and durable immune tolerance in mice by preventing T cells from attacking the myelin sheath.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE